Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
MAR Marriott International beats Q1 estimates with 55 EPS surprise revenue climbs 43 as hotel demand remains resilient Is Broadridge BR stock showing breakdown risk Q1 2026 EPS Exceeds Expectations Yext YEXT Stock Trend Strength Evaluation Investors Pile In 20260418 RTX Corporation RTX Q1 Earnings Beat Overshadowed by Geopolitical Volatility LongTerm Bullish Thesis Remains Intact Acuity AYI Stock Continuation Trade Calm 20260423 Biogen Inc BIIB Bullish Analyst Commentary and Institutional Positioning Signal Positive Upside Trajectory How Chiron XRN is reshaping its industry Bullish Sentiment 20260511 Financial Services Roundup Market Talks Highlight Experian SoFi Technologies and Sector Trends Kevin Warsh Faces Divided Fed Over Rate Cuts as Inflation and Yields Surge IT Stocks Gain Up to 3 Amid Market Turbulence Infosys OFSS TechM Lead Catalyst CLST Earnings Outlook Key Metrics for Q3 2025 PlayStation Plus Announces Monthly Subscription Fee Increase Amid Ongoing Market Conditions What Omada Health OMDAs 079 Jump Means for Investors 20260519 Shark Attack in Queensland Raises Safety Concerns for Coastal Tourism Sector UK Heatwave Drives Surge in Fan Ice Cube and Sunscreen Sales AI Data Center Boom Strains Power Grid Raising Utility Costs for Consumers Futures Rise as USIran Talks Signal Potential Deescalation TTM Technologies TTMI Identified as Potential Multibagger Stock for 2026 Vedanta MCX Lead Retail Shareholding Surge in Q4 Market Trends BZFD Q1 2026 Earnings EPS Misses Estimates Stock Declines UDR Q1 2026 Earnings Massive EPS Beat Drives Modest Stock Uplift FormFactor Q1 2026 Earnings EPS Beats Estimates by Wide Margin BODI Q1 2026 Earnings EPS Surges to 030 Smashing Estimates by 2634 CREG Q1 2026 Earnings Reported Loss Per Share of 003 Stock Declines 125 Amid Missing Revenue Data General Mills Q1 2026 Earnings EPS Misses Estimates by Nearly 13 as Stock Edges Higher Quince Therapeutics QNCX Jumps 9 Testing Key Resistance at 126 Aligos Therapeutics ALGS Posts Modest Gain Holds Near Support Zone Zevra Therapeutics ZVRA Gains 411 as Stock Tests Key Resistance Zone Sharps Technology Inc STSS Pulls Back Toward Support After Recent Downside Move Brookfield Infrastructure Partners BIP Holds Near Support Amid Modest Decline